id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2022-E-0680-0007,FDA,FDA-2022-E-0680,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2025-01-13T05:00:00Z,2025,1,2025-01-13T05:00:00Z,,2025-01-13T20:01:42Z,,0,0,09000064868b75ef
FDA-2022-E-0680-0006,FDA,FDA-2022-E-0680,Letter from U. S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2024-01-17T05:00:00Z,2024,1,2024-01-17T05:00:00Z,,2024-01-17T19:00:44Z,,0,0,0900006486388b97
FDA-2022-E-0680-0005,FDA,FDA-2022-E-0680,Letter from FDA CDER TO U.S. Patent and Trademark Office,Other,Letter(s),2023-12-01T05:00:00Z,2023,12,2023-12-01T05:00:00Z,,2023-12-01T20:26:15Z,,0,0,09000064862d4405
FDA-2022-E-0680-0004,FDA,FDA-2022-E-0680,Determination of Regulatory Review Period for Purposes of Patent Extension; Amondys 45,Notice,Determinations,2023-11-30T05:00:00Z,2023,11,2023-11-30T05:00:00Z,2024-05-29T03:59:59Z,2023-11-30T18:10:37Z,2023-26299,0,0,09000064862c32e0
FDA-2022-E-0680-0003,FDA,FDA-2022-E-0680,Letter from FDA CDER to U S Patent and Trademark Office,Other,Letter(s),2022-06-14T04:00:00Z,2022,6,2022-06-14T04:00:00Z,,2022-06-14T16:05:56Z,,0,0,0900006485162db9
FDA-2022-E-0680-0001,FDA,FDA-2022-E-0680,Letter from U.S. Patent and Trademark Office,Other,Letter(s),2022-04-26T04:00:00Z,2022,4,2022-04-26T04:00:00Z,,2022-04-26T12:52:07Z,,0,0,09000064850359e8
FDA-2022-E-0680-0002,FDA,FDA-2022-E-0680,"Patent Extension Application from Sterne, Kessler, Goldstein & Fox P.L.L.C. (on behalf of The University of Western Australia)",Other,Application,2022-04-26T04:00:00Z,2022,4,2022-04-26T04:00:00Z,,2022-04-26T12:52:12Z,,0,0,0900006485035b8d